European Journal of Rheumatology
Original Article

Neutrophil-lymphocyte ratio in children with familial Mediterranean fever: original article

1.

Department of Pediatrics, Division of Pediatric Immunology and Allergy, Cumhuriyet University Faculty of Medicine, Sivas, Turkey

2.

Department of Pediatrics, Division of Pediatric Nefrology, Cumhuriyet University Faculty of Medicine, Sivas, Turkey

3.

Department of Pediatrics, Cumhuriyet University Faculty of Medicine, Sivas, Turkey

Eur J Rheumatol 2015; 2: 20-23
DOI: 10.5152/eurjrheumatol.2015.0093
Read: 222 Downloads: 38 Published: 03 September 2019

Abstract

Objective: The aim of present study was (a) to evaluate the relationship between the neutrophil/lymphocyte (N/L) ratio and mutation types of familial Mediterranean fever (FMF) in children and (b) to evaluate the relationship between the N/L ratio and age.

 

Material and Methods: Three hundred forty-three children with familial Mediterranean fever in the attack-free period and 283 healthy control children were included in the study. Patients were divided into subgroups according to mutation types. Neutrophil and lymphocyte counts were retrieved from medical records of patients and the N/L ratio was calculated from these parameters.

 

Results: The N/L ratio of patients was found to be significantly higher than that of controls (p<0.001). Among 343 patients, homozygous, heterozygous, and compound mutations were observed in 39, 253, and 51 patients, respectively. The differences in the N/L ratio among patients with homozygous, heterozygous, and compound mutations were not statistically significant. The most common mutations were M694V (n=126), E148Q (n=70), M680I, (n=33), and V726A (n=28). Significant differences were not observed among these mutations in terms of the N/L ratio (p>0.05). In all subjects, there was a weak but significant relationship between age and the N/L ratio (r: 0.215, p<0.001).

 

Conclusion: The N/L ratio, which can be determined by simple methods in routine blood tests,  may be used for the follow-up monitoring of chronic inflammation in patients. In addition, the N/L ratio may give an idea to clinicians regarding the early initiation of treatment in patients with typical clinical findings of FMF.

 

Files
ISSN2147-9720 EISSN 2148-4279